These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31432398)

  • 1. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
    Gillard J; van Schuppen E; Diavatopoulos DA
    Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Immune Responses to Pertussis Vaccines.
    Ausiello CM; Mascart F; Corbière V; Fedele G
    Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Mucosal Immunity in Pertussis.
    Solans L; Locht C
    Front Immunol; 2018; 9():3068. PubMed ID: 30692990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin Clears
    Borkner L; Misiak A; Wilk MM; Mills KHG
    Front Immunol; 2018; 9():1764. PubMed ID: 30105030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement evasion by Bordetella pertussis: implications for improving current vaccines.
    Jongerius I; Schuijt TJ; Mooi FR; Pinelli E
    J Mol Med (Berl); 2015 Apr; 93(4):395-402. PubMed ID: 25686752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.
    Kim AR; Sette A; da Silva Antunes R
    Expert Rev Vaccines; 2024; 23(1):705-714. PubMed ID: 39037200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to Bordetella pertussis.
    Mills KH
    Microbes Infect; 2001 Jul; 3(8):655-77. PubMed ID: 11445452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waning and aging of cellular immunity to Bordetella pertussis.
    van Twillert I; Han WG; van Els CA
    Pathog Dis; 2015 Nov; 73(8):ftv071. PubMed ID: 26371178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics of Bordetella pertussis whole-cell and acellular vaccines.
    Möller J; Kraner ME; Burkovski A
    BMC Res Notes; 2019 Jun; 12(1):329. PubMed ID: 31182148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
    Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
    Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.